Formulation aspects of biodegradable polymeric microspheres for antigen delivery

Advanced Drug Delivery Reviews

Volumn 57, Issue 3 SPEC. ISS., 2005, Pages 357-376

  Tamber, Harjit ^a,b   Johansen, Pål ^a,c   Merkle, Hans P ^a   Gander, Bruno ^a  

^a ETH ZURICH   (Switzerland)

^b Napp Pharmaceuticals Research Ltd   (United Kingdom)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Antigen microencapsulation; Antigen release; Antigen stability; PLGA microspheres

Indexed keywords

BIODEGRADATION; CELLS; IMMUNOLOGY; ORGANIC POLYMERS; PROTEINS;

BIODEGRADABLE MICROSPHERES (MS); IMMUNOCOMPETENT CELLS; MICROENCAPSULATED MATERIAL;

ANTIGENS;

ANTIGEN; CYCLODEXTRIN; MACROGOL 3350; MICROSPHERE; PEPTIDE; POLOXAMER; POLYGLACTIN; POLYMER; VACCINE;

ADDITION REACTION; BIODEGRADABILITY; CHEMICAL COMPOSITION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HYDROPHOBICITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MICROENCAPSULATION; NEBULIZATION; PH; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY;

EID: 9244255681     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2004.09.002     Document Type: Review

References (154)

1. C.E.M. Allsop, M. Plebanski, S. Gilbert, R.E. Sinden, S. Harris, G. Frankel, G. Dougan, C. Hioe, D. Nixon, E. Paoletti, G. Layton, and A.V.S. Hill Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunisation Eur. J. Immunol. 26 1996 1951 1959
2. D.M. Gordon Use of novel adjuvants and delivery systems to improve the humoral and cellular response to malaria vaccine candidate antigens Vaccine 11 1993 591 593
3. R.K. Gupta, G.R. Siber, M.J. Alonso, and R. Langer Development of a single-dose tetanus toxoid based on controlled release from biodegradable and biocompatible polyester microspheres H.S. Ginsberg F. Brown R.M. Chanock R.A. Lerner Modern Approaches to New Vaccines Including Prevention of AIDS Vaccine 93 1993 Cold Spring Harbor Laboratory Press New York 391 396
4. N. Garcon Delivery systems: the long road to human vaccines B. Gander H.P. Merkle G. Corradin Antigen Delivery Systems 1997 Harwood Academic Publishers Amsterdam 47 56
5. P. Johansen, G. Corradin, H.P. Merkle, and B. Gander Release of tetanus toxoid from adjuvants and PLGA microspheres: how the experimental set-up and surface adsorption fool the pattern J. Control. Release 56 1998 209 217
6. M.T. Aguado, and P.H. Lambert Controlled-release vaccines-biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles Immunobiology 184 1992 113 125
7. J.L. Cleland, L. Barron, P.W. Berman, A. Daugherty, T. Gregory, A. Lim, J. Vennari, T. Wrin, and M.F. Powell Developmentof a single-shot subunit vaccine for HIV-1: 2. Defining optimal auto boost characteristics to maximise the humoral immune response J. Pharm. Sci. 85 1996 1346 1349
8. Y. Men, B. Gander, H.P. Merkle, and G. Corradin Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres Vaccine 14 1996 1442 1450
9. J.L. Cleland, A. Lim, L. Barron, E.T. Duenas, and M.F. Powell Development of a single-shot subunit vaccine for HIV-1: part 4. Optimising microencapsulation and pulsatile release of MN rgp120 from biodegradable microspheres J. Control. Rel.ease 47 1997 135 150
10. C. Thomasin, G. Corradin, Y. Men, H.P. Merkle, and B. Gander Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co- glycolide) microspheres: importance of polymer degradation and antigen release for immune response J. Control. Release 41 1996 131 145
11. T. Kissel, A.K. Hilbert, R. Konenberg, and B. Bittner Microencapsulation of antigens for parenteral vaccine delivery system B. Gander H.P. Merkle G. Corradin Antigen Delivery Systems 1997 Harwood Academic Publishers Amsterdam 159 190
12. E. Walter, D. Dreher, M. Kok, L. Thiele, S.G. Kiama, P. Gehr, and H.P. Merkle Hydrophilic poly(dl-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells J. Control. Release 76 2001 149 168
13. J. Hanes, J.L. Cleland, and R. Langer New advances in microsphere-based single-dose vaccines Adv. Drug Deliv. Rev. 28 1997 97 119
14. J.L. Cleland Development of stable formulations for PLGA/PLA microsphere vaccines Res. Immunol. 149 1998 45 47
15. S.P. Schwendeman, M. Cardamone, A. Klibanov, R. Langer, and M.R. Brandon Stability of proteins and their delivery from biodegradable polymer microspheres S. Cohen H. Bernstein Microparticulate Systems for the Delivery of Proteins and Vaccines 1996 Marcel Dekker New York 1 47
16. J.L. Cleland, and A.J.S. Jones Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres Pharm. Res. 13 1996 1464 1475
17. T. Uchida, A. Yagi, Y. Oda, Y. Nakada, and S. Goto Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres Chem. Pharm. Bull. 44 1996 235 236
18. P. Johansen, Y. Men, R. Audran, G. Corradin, H.P. Merkle, and B. Gander Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives Pharm. Res. 15 1998 1103 1110
19. A. Sanchez, B. Villamayor, Y. Guo, J. McIver, and M.J. Alonso Formulation strategies for the stabilisation of tetanus toxoid in poly(lactide-co- glycolide) microspheres Int. J. Pharm. 185 1999 255 266
20. H.K. Lee, J.H. Park, and K.C. Kwan Double-walled microparticles for single shot vaccine J. Control. Release 44 1997 283 293
21. H. Ueda, and Y. Tabata Polyhydroxyalkanonate derivatives in current clinical applications and trials Adv. Drug Deliv. Rev. 55 2003 501 518
22. S. Prior, B. Gander, N. Blarer, H.P. Merkle, M.L. Subira, J.M. Irache, and C. Gamazo In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres Eur. J. Pharm. Sci. 15 2002 197 207
23. D.H. Lewis Controlled release of bioactive agents from lactide/glycolide polymers M. Chasin R. Langer Biodegradable Polymers as Drug Delivery Systems 1990 Marcel Dekker New York 1 41
24. S.M. Li, H. Garreau, and M. Vert Structure-property relationships in the case of the degradation of massive aliphatic poly-(a-hydroxy acids) in aqueous media. Part 2: Degradation of lactide-glycolide copolymers: PLA37.5GA25 and PLA75GA25 J. Mater. Sci., Mater. Med. 1 1990 131 139
25. A. Göpferich Mechanisms of polymer degradation and erosion Biomaterials 17 1996 103 114
26. C.G. Pitt, M.M. Gratzel, G.L. Kimmel, J. Surles, and A. Schindler Aliphatic polyesters 2. The degradation of poly(d,llactide) poly(ε- caprolactone) and their copolymers in vivo Biomaterials 2 1981 215 220
27. K. Fu, D.W. Pack, A.M. Klibanov, and R. Langer Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres Pharm. Res. 17 2000 100 106
28. R. Jain, N.H. Shah, A.W. Malick, and C.T. Rhodes Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches Drug Dev. Ind. Pharm. 28 1998 703 727
29. T. Kissel, R. Koneberg, A.K. Hilbert, and K.D. Hungerer Microencapsulation of antigens using biodegradable polyesters: facts and phantasies Behring-Inst.-Mitt. 98 1997 172 183
30. C. Thomasin, H.P. Merkle, and B. Gander Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation J. Pharm. Sci. 87 1998 269 275
31. C. Thomasin, H. Nam-Tran, H.P. Merkle, and B. Gander Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations J. Pharm. Sci. 87 1998 259 268
32. R. Bodmeier, and J.W. McGinity Solvent selection in the preparation of poly(d,l-lactide) microspheres prepared by the solvent evaporation method Int. J. Pharm. 43 1988 179 186
33. B. Gander, P. Johansen, H. Nam-Tran, and H.P. Merkle Thermodynamic approach to protein microencapsulation into poly(d,l-lactide) by spray drying Int. J. Pharm. 129 1996 51 61
34. M. Singh, X.M. Li, J.P. McGee, T. Zamb, W. Koff, C.Y. Wang, and D.T. O'Hagan Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice Vaccine 15 1997 475 481
35. C.R. Howard, A.J. Beale, and M.T. Aguado The development of controlled release vaccines-the role of the World Health Organisation B. Gander H.P. Merkle G. Corradin Antigen Delivery Systems 1997 Harwood Academic Publishers Amsterdam 1 14
36. T.M. Kundig, M.F. Bachmann, P.S. Ohashi, H. Pircher, H. Hengartner, and R.M. Zinkernagel On T cell memory: arguments for antigen dependence Immunol. Rev. 150 1996 63 90
37. M.F. Bachmann, B. Odermatt, H. Hengartner, and R.M. Zinkernagel Induction of long-lived germinal centers associated with persisting antigen after viral infection J. Exp. Med. 183 1996 2259 2269
38. T. Kissel, and R. Koneberg Injectable biodegradable microspheres for vaccine delivery S. Cohen H. Bernstein Microparticulate Systems for the Delivery of Proteins and Vaccines 1996 Marcel Dekker New York 51 87
39. S. Li, C. Schöneich, and R.T. Borchardt Chemical instability of proteins Pharm. News 2 1995 12 16
40. M.C. Manning, K. Patel, and R.T. Borchardt Stability of protein pharmaceutics Pharm. Res. 6 1989 903 918
41. R. Pearlman, and T.A. Bewley Stability and characterization of human growth hormone Y.J. Wang R. Pearlman Stability and Characterisation of Protein and Peptide Drugs: Case Histroies 1993 Plenum Press New York 1 58
42. G. Crotts, and T.G. Park Stability and release of bovine serum albumin encapsulated within poly(d,l-lactide-co-glycolide) microparticles J. Control. Release 44 1997 123 134
43. H.K. Sah Protein behaviour at the water/methylene chloride interface J. Pharm. Sci. 88 1999 1320 1325
44. P. Johansen, H. Tamber, H.P. Merkle, and B. Gander Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs Eur. J. Pharm. Biopharm. 47 1999 193 201
45. P. Johansen, H.P. Merkle, and B. Gander Physico-chemical and antigenic properties and improved stability of tetanus and diptheria toxoids Biochim. Biophys. Acta 1425 1998 425 436
46. G. Boehm, M. Peyre, D. Sesardic, R.J. Huskisson, F. Mawas, A. Douglas, D. Xing, H.P. Merkle, B. Gander, and P. Johansen On technological and immunological benefits of multivalent single-injection microsphere vaccines Pharm. Res. 19 2002 1330 1336
47. M. Peyre, D. Sesardic, H.P. Merkle, B. Gander, and P. Johansen An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria J. Pharm. Sci. 92 2003 957 966
48. R.S. Raghuvanshi, S. Ganga, A. Misra, and S. Mehta Stabilisation of tetanus toxoid against dichloromethane Proc. Int. Symp. Control Release Bioact. Mater. 23 1996 859 860
49. M. Morlock, H. Koll, G. Winter, and T. Kissel Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilising excipients Eur. J. Pharm. Biopharm. 43 1997 29 36
50. A.C. Chang, and R.K. Gupta Stabilisation of tetanus toxoid in poly(dl-lactic-co-glycolic acid) microspheres for the controlled release of antigen J. Pharm. Sci. 85 1996 129 131
51. Y. Ogawa, M. Yamamoto, H. Okada, T. Yashiki, and T. Shimamoto A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid Chem. Pharm. Bull. 36 1988 1095 1103
52. T. Uchida, K. Shiosaki, Y. Nakada, K. Fukada, Y. Eda, S. Tokiyoshi, N. Nagareya, and K. Matsuyama Microencapsulation of hepatitis B core antigen for vaccine preparation Pharm. Res. 15 1998 1708 1713
53. M. Singh, A. Singh, and G.P. Talwar Controlled delivery of diptheria toxoid using biodegradable poly(d,l-lactide) microcapsules Pharm. Res. 8 1991 958 961
54. M. Singh, O. Singh, and G.P. Talwar Biodegradable delivery system for a birth control vaccine: immunogenicity studies in rats and monkeys Pharm. Res. 12 1995 1796 1800
55. T. Arakawa, and Y. Kita Protection of bovine serum albumin from aggregation by Tween 80 J. Pharm. Sci. 89 2000 646 651
56. M.A. Hanson, and S.K.E. Rouan Introduction to formulation of protein pharmaceuticals T.J. Ahern M.C. Manning Stability of Protein Pharmaceuticals. Part B. In Vivo Pathways of Degradation and Strategies for Protein Stabilisation 1992 Plenum Press New York 209 233
57. M.J. Alonso, R.K. Gupta, C. Min, G.R. Siber, and R. Langer Biodegradable microspheres as controlled-release tetanus toxoid delivery systems Vaccine 12 1994 299 306
58. M.D. Blanco, and M.J. Alonso Development and characterisation of protein-loaded poly(lactide-co-glycolide) nanospheres Eur. J. Pharm. Biopharm. 43 1997 287 294
59. N. Nihant, C. Schugens, C. Grandfils, R. Jerôme, and P. Teyssie Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability Pharm. Res. 11 1994 1479 1484
60. C. Sturesson, and L. Degling Wikingsson Comparison of poly(acryl starch) and poly(lactide-co-glycolide) microspheres as drug delivery system for a rotavirus vaccine J. Control. Release 68 2000 441 450
61. N.B. Bam, T.W. Randolph, and J.L. Cleland Stability of protein formulations: investigation of surfactant effects by a novel EPR spectroscopic technique Pharm. Res. 12 1995 2 11
62. M.J. Pikal Freeze-drying of proteins. Part II. Formulation selection Pharm. Technol. Int. 1991 40 43
63. J.C. Lee, and S.N. Timasheff The stabilisation of proteins by sucrose J. Biol. Chem. 256 1981 7193
64. T. Arakawa, Y. Kita, and J.F. Carpenter Protein-solvent interactions in pharmaceutical formulations Pharm. Res. 8 1991 285 291
65. M. Morlock, T. Kissel, Y.X. Li, H. Koll, and G. Winter Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilisation and in vitro release J. Control. Release 56 1998 105 115
66. Y. Zhou, and C.K. Hall Solute excluded-volume effects on the stability of globular proteins: a statistical thermodynamic theory Biopolymers 38 1996 273 284
67. J.E. Eyles, G.J.E. Sharp, E.D. Williamson, I.D. Spiers, and H.O. Alpar Intra-nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse Vaccine 16 1998 698 707
68. J.E. Eyles, I.D. Spiers, E.D. Williamson, and H.O. Alpar Analaysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines Vaccine 16 1998 2000 2009
69. B. Baras, M.A. Benoit, O. Poulain-Godefroy, A.M. Schacht, A. Capron, J. Gillard, and G. Riveau Vaccine properties of antigens entrapped in microparticles produced by spray-drying technique and using various polyester polymers Vaccine 18 2000 1495 1505
70. P.B. O'Donnel, and J.W. McGinity Preparation of microspheres by the solvent evaporation technique Adv. Drug Deliv. Rev. 28 1997 25 42
71. K. Matsuyama, S. El-Gizway, and J.H. Perrin Thermodynamics of binding of aromatic amino acids to α, β, and γ-cyclodextrins. Drug Dev. Ind. Pharm. 13 1987 2687 2691
72. R.K. Gupta, A.C. Chang, and G.R. Siber Biodegradable polymer microspheres as vaccine adjuvants and delivery systems B.F. Haaheim Modulation of the Immune Response to Vaccine Antigens 1998 Karger Basel 63 78
73. B. Gander, E. Wehrli, R. Alder, and H.P. Merkle Quality improvement of spray-dried, protein-loaded d,l-PLA microspheres by appropriate polymer solvent selection J. Microencapsul. 12 1995 83 97
74. I.J. Castellanos, K.G. Carasquillo, J.D. Jesus Lopez, M. Alvarez, and K. Griebnow Encapsulation of bovine serum albumin in poly(lactide-co.glycolide) microspheres by the solid-in-oil-in-water technique J. Pharm. Pharmacol. 53 2001 167 178
75. K.G. Carrrasquillo, J.C.A. Carro, A. Alejandro, D.D. Toro, and K. Griebenow Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation J. Pharm. Pharmacol. 53 2001 115 120
76. T. Morita, Y. Sakamura, Y. Horikiri, T. Suzuki, and H. Yoshino Protein encapsulation into biodegradable microspheres by a S/O/W emulsion method using poly(ethylene glycol) as a pre-micronization adjuvant J. Control. Release 69 2000 435 444
77. H.S. Yoo, H.K. Choi, and T.G. Park Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles J. Pharm. Sci. 90 2001 194 201
78. R. Audran, Y. Men, P. Johansen, B. Gander, and G. Corradin Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilising agents Pharm. Res. 15 1998 1111 1116
79. G. Zhu, S.R. Mallery, and S.P. Schwendeman Stabilisation of proteins encapsulated in injectable poly(lactide-co-glycolide) Nat. Biotechnol. 18 2000 52 57
80. G. Zhu, and S.P. Schwendeman Stabilisation of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanisms of stabilisation by basic additives Pharm. Res. 17 2000 351 357
81. K. Hallas-Möhler, K. Petersen, and J. Schlichtkrull Crystalline and amorphous insulin-zinc compounds with prolonged action Science 116 1952 394 398
82. U. Gietz, T. Arvinte, M. Haner, U. Aebi, and H.P. Merkle Formulation of sustained release aqueous Zn-hirudin suspensions Eur. J. Pharm. Sci. 11 2000 33 41
83. B.C. Cunningham, M.G. Mulkerrin, and J.A. Wells Dimerisation of human growth hormone by zinc Science 253 1991 545 548
84. O.L. Johnson, J.L. Cleland, H.J. Lee, M. Charnis, E. Duenas, W. Jaworowicz, D. Shepard, A. Shahzamani, A.J.S. Jones, and S.D. Putney A month-long effect from a single injection of microencapsulated human growth hormone Nat. Med. 2 1996 795 799
85. O.L. Johnson, W. Jarworowicz, J.L. Cleland, L. Bailey, M. Charnis, E. Duenas, C. Wu, D. Shepard, S. Magil, T. Last, A.J.S. Jones, and S.D. Putney The stabilisation and encapsulation of human growth hormone into biodegradable microspheres Pharm. Res. 14 1997 730 735
86. C.O. Fágáin Understanding and increasing protein stability Biochim. Biophys. Acta 1252 1995 1 14
87. W.R. Liu, R. Lander, and A.M. Klibanov Moisture-induced aggregation of lyophilised proteins in the solid state Biotechnol. Bioeng. 37 1991 177 184
88. S.P. Schwendeman, H.R. Costantino, R.K. Gupta, G.R. Siber, A.M. Klibanov, and R. Langer Stabilisation of tetanus and diptheria toxoids against moisture-induced aggregation Proc. Nat. Acad. Sci. U. S. A. 92 1995 11234 11238
89. C.K. Kim, and E.J. Jeong Development of dried liposome as effective immuno-adjuvant for hepatitis B surface antigen Int. J. Pharm. 115 1995 193 199
90. A.K. Hilbert, U. Fritzsche, and T. Kissel Biodegradable microspheres containing influenza A vaccine: immune response in mice Vaccine 17 1999 1065 1073
91. M. Madiba, and X.S. Wu Preparation and characterisation of protein-containing PLGA-phospholipid composite Proc. Int. Symp. Control. Release Bioact. Mater. 23 1996 813 814
92. L.H. Brinkerhoff, V.V. Kalashnikov, L.W. Thompson, R.A. Yamshchikov, H.S. Galavotti, V.H. Engelhard, and C.L. Slingluff Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1 (27-35) peptide: implications for peptide vaccines Int. J. Cancer 83 1999 326 334
93. P.I. Guerra, C. Acklin, A.A. Kosky, J.M. Davis, M.J. Treuheit, and D.M. Brems PEGylation prevents the N-terminal degradation of megakaryocyte growth and development factor Pharm. Res. 15 1998 1822 1827
94. M. Diwan, and T.G. Park Pegylation enhances protein stability during encapsulation in PLGA microspheres J. Control. Release 73 2001 233 244
95. G.E. Francis, D. Fisher, C. Delgado, F. Malik, A. Gardiner, and D. Neale PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optomisation of coupling techniques Int. J. Hematol. 68 1998 1 18
96. H. Huatan, J.H. Collet, D. Attwood, and C. Booth Preparation and characterisation of poly(ε-caprolactone) polymer blends for the delivery of proteins Biomaterials 16 1995 1297 1303
97. H. Huatan, J.H. Collett, and D. Attwood The microencapsulation of protein using a novel ternary blend based on poly(ε-caprolactone) J. Microencapsul. 12 1995 557 567
98. S.E.M. Ibim, A.M.A. Ambrosio, M.S. Kwon, S.F. El-Amin, H.R. Allcock, and C.T. Laurencin Novel polyphosphazene/poly(lactide-co-glycolide) blends: miscibility and degradation studies Biomaterials 18 1997 1565 1569
99. H.B. Ravivarapu, K. Burton, and P.P. DeLuca Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres Eur. J. Pharm. Biopharm. 50 2000 263 270
100. J.L. Eguiburu, J.J. Iruin, M.J. Fernandez-Berridi, and J.S. Roman Blends of amorphous and crystalline polylactides with poly(methyl methacrylate) and poly(methyl methacylate): a miscibility study Polymer 39 1998 6891 6897
101. M. Tobio, and M.J. Alonso Study of the inactivation process of tetanus toxoid in the presence of PLGA degrading microspheres S.T.P. Pharm. Sci. 8 1998 303 310
102. M. Tobio, J. Nolley, Y. Guo, J. McIver, and M.J. Alonso A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle Pharm. Res. 16 1999 682 688
103. W. Jiang, and S.P. Schwendeman Stabilisation and controlled release of bovine serum albumin encapsulated in poly(d,l-lactide) and poly(ethylene glycol) microsphere blends Pharm. Res. 18 2001 878 885
104. M.K. Yeh The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol J. Microencapsul 17 2000 743 756
105. E.C. Lavelle, M.K. Yeh, A.G.A. Coombes, and S.S. Davis The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol Vaccine 17 1999 512 529
106. P. Bouillot, N. Ubrich, F. Sommer, T.M. Duc, J.P. Loeffler, and E. Dellacherie Protein encapsulation in biodegradable amphiphilic microspheres Int. J. Pharm. 181 1999 159 172
107. X. Li, Y. Zhang, R. Yan, W. Jia, M. Yuan, X. Deng, and Z. Huang Influence of process parameters on the protein stability encapsulated in poly-dl-lactide-poly(ethylene glycol) microspheres J. Control. Release 68 2000 41 52
108. X.M. Deng, X.H. Li, M.L. Yuan, C.D. Xiong, C.D. Huang, W.X. Jia, and Y.H. Zhang Optimisation of preparative conditions for poly-dl-lactide-polyethylene glycol microspheres with entrapped Vibrio cholera antigens J. Control. Release 58 1999 123 131
109. X. Li, X. Deng, M. Yuan, C. Xiong, Z. Huang, Y. Zhang, and W. Jia Investigation on process parameters involved in preparation of poly-dl-lactide-poly(ethylene glycol) microspheres containing Leptospira interrogans antigens Int. J. Pharm. 178 1999 245 255
110. G. Rafler, M. Jobmann, and M. Bernd Hydrophobe resorbierbare Polyester und deren Verwendung 1996 European Patent Office Germany
111. G. Rafler, and M. Jobmann 4th Communication: hydrophobic and hydrophilic polylactides for drug delivery systems Pharm. Ind. 58 1996 1147 1151
112. H. Tamber, Development of biodegradable polymer microspheres for peptide/protein antigen delivery, Ph.D. thesis, ETH, Zuerich, 2002.
113. P. Johansen, L. Moon, H. Tamber, H.P. Merkle, B. Gander, and D. Sesardic Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs Vaccine 18 1999 209 215
114. J. Heller, J. Barr, S.Y. Ng, H.-R. Shen, K. Swatch-Abdellaoui, S. Emmahl, A. Rothen-Weinhold, and R. Gurny Poly(ortho esters)-their development and some recent applications Eur. J. Pharm. Biopharm. 50 2000 121 128
115. Y.Y. Yang, J.P. Wan, T.S. Chung, P.K. Pallathadka, S. Ng, and J. Heller POE-PEG-POE triblock coploymeric microspheres containing protein. I. Preparation and characterisation J. Control. Release 75 2001 115 128
116. J.P. Wan, Y.Y. Yang, T.S. Chung, D. Tan, S. Ng, and J. Heller POE-PEG-POE triblock coploymeric microspheres containing protein. II. Polymer erosion and protein release mechanism J. Control. Release 75 2001 129 141
117. J.M. Bezemer, R. Radersma, D.W. Grijpma, P.J. Dijkstra, C.A. van Blitterswijk, and J. Feijen Microspheres for protein delivery prepared from amphiphilic multiblock copolymers. 2. Modulation of release rate J. Control. Release 67 2000 249 260
118. T. Jung, A. Breitenbach, and K. T. Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres J. Control. Release 67 2000 157 169
119. T. Jung, W. Kamm, A. Breitenbach, G. Klebe, and T. Kissel Loading of tetanus toxoid to biodegradable nanoparticles from branched poly(sulfobutyl- polyvinyl alcohol)-g-(lactide-co-glycolide) nanoparticles by protein adsorption: a mechanistic study Pharm. Res. 19 2002 1105 1113
120. X.W. Li, D.K. Lee, A.S. Chan, and H.O. Alpar Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles Biochim. Biophys. Acta 1630 2003 7 18
121. J. Herrmann, and R. Bodmeier Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods Eur. J. Pharm. Biopharm. 45 1998 75 82
122. M. Singh, B. Shirley, K. Bajwa, E. Samara, M. Hora, and D. O'Hagan Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles J. Control. Release 70 2001 21 28
123. N. Badri Viswanathan, P.A. Thomas, J.K. Pandit, M.G. Kulkarni, and R.A. Mashelkar Preparation of non-porous microspheres with high entrapment efficiency of proteins by a (water-in-oil)-in-oil emulsion technique J. Control. Release 58 1999 9 20
124. A. Sanchez, R.K. Gupta, M.J. Alonso, G.R. Siber, and R. Langer Pulsed controlled-release system for potential use in vaccine delivery J. Pharm. Sci. 85 1996 547 552
125. S. Freitas, A. Walz, H.P. Merkle, and B. Gander Solvent extraction employing a static micromixer: a simple, robust and versatile technology for the microencapsulation of proteins J. Microencapsul. 20 2003 67 85
126. T.W. Randolph, A.D. Randolph, M. Mebes, and S. Yeung Sub-micrometer-sized biodegradable particles of poly(l-lactic acid) via the gas antisolvent spray precipitation process Biotechnol. Prog. 9 1993 429 435
127. J. Bleich, and B.W. Müller Production of drug loaded microparticles by the use of supercritical gases with aersol solvent extraction system (ASES) process J. Microencapsul. 13 1996 131 139
128. P.G. Debenedetti, J.W. Tom, S.D. Yeo, and G.B. Lim Application of supercritical fluids for the production of sustained delivery devices J. Control. Release 24 1993 27 44
129. C. Bitz, and E. Doelker Influence of the preparation method on residual solvents in biodegradable microspheres Int. J. Pharm. 131 1996 171 181
130. C. Witschi, and E. Doelker Peptide degradation during preparation and in vitro release testing of poly(l-lactic acid) and poly(dl-lactic-co-glycolic acid) microparticles Int. J. Pharm. 171 1998 1 18
131. A. Breitenbach, D. Mohr, and T. Kissel Biodegradable semi-crystalline comb polymers influence the microsphere production by means of a supercritical fluid extraction technique J. Control. Release 63 2000 53 68
132. A. Engwicht, U. Girreser, and B.W. Muller Critical properties of lactide-co-glycolide polymers for the use of microparticle preparation by the aerosol solvent extraction system Int. J. Pharm. 185 1999 61 72
133. R.T. Bartus, M.A. Tracey, D.F. Emerich, and S.E. Zale Sustained delivery of novel therapeutic products Science 281 1998 1161 1162
134. J.D. Herberger, C. Wu, N. Dong, and M.A. Tracy Characterisation of Prolease® human growth hormone PLGA microspheres produced using different solvents Proc. Int. Symp. Control. Release Bioact. Mater. 23 1996 835 836
135. J.L. Cleland, E.T. Duenas, A. Park, A. Daugherty, J. Kahn, J. Kowalski, and A. Cuthbertson Development of poly-(d,l-lactide-co-glycolide) microsphere formulations containing recombinant human vascualr growth factoer to promote local angiogenesis J. Control. Release 72 2000 13 24
136. X.M. Lam, E.T. Duenas, A.L. Daugherty, N. Levin, and J.L. Cleland Sustained release of recombinant human insulin-like growth factor-I for treatement of diabetes J. Control. Release 67 2000 281 292
137. C.B. Felder, M.J. Blanco-Príeto, J. Heizmann, H.P. Merkle, and B. Gander Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters J. Microencapsul. 20 2003 553 567
138. S. Freitas, H.P. Merkle, and B. Gander Ultrasonic atomisation into reduced pressure atmosphere-envisaging aseptic spray-drying for microencapsulation J. Control. Release 95 2004 185 195
139. C. Berkland, K. Kim, and D.W. Pack Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions J. Control. Release 73 2001 59 74
140. R.A. Jain, C.T. Rhodes, A.M. Railkar, A.W. Malik, and N.H. Shah Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables Eur. J. Pharm. Biopharm. 50 2000 257 262
141. M. Briones, M. Singh, M. Ugozzoli, J. Kazzaz, S. Klakamp, G. Ott, and D. O'Hagan The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery Pharm. Res. 18 2001 709 712
142. J. Kazzaz, J. Neidleman, M. Singh, G. Ott, and D.T. O'Hagan Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1 J. Control. Release 67 2000 347 356
143. M. Singh, M. Briones, G. Ott, and D. O'Hagan Cationic microparticles: a potent delivery system for DNA vaccines Proc. Nat. Acad. Sci. U. S. A. 97 2000 811 816
144. M. Singh, J. Kazzaz, M. Ugozzoli, J. Chesko, and D. O'Hagan Charged poly(lactide-co-glycolide) microparticles as novel antigen delivery systems Expert Opin. Biol. Ther. 4 2004 483 491
145. L. Tondelli, E. Canto, A. Pistagna, S. Butt, A. Tripiciano, R. Cortesi, K. Sparnacci, and M. Laus Tailor-made core-shell nanospheres for antisense oligonucleotide delivery: IV. Adsorption/release behaviour J. Biomater. Sci., Polym. Ed. 12 2001 1339 1357
146. K.N. Atuah, E. Walter, H.P. Merkle, and H.O. Alpar Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods J. Microencapsul. 20 2003 387 399
147. R.E. Johnson, L.A. Lanaski, V. Gupta, H.T. Griffin, H.T. Gaud, T.E. Needham, and H. Zia Stability of atriopeptin III in poly(d,l-lactide-co- glycolide) microspheres J. Control. Release 17 1991 61 67
148. Y. Aso, S. Yoshioka, A. Li Wan Po, and T. Terao Effect of temperature on mechanisms of drug release and matrix degradation of poly(d,l-lactide) microspheres J. Control. Release 31 1994 33 39
149. S.D. Putney, and P.A. Burke Improving protein therapeutics with sustained-release formulations Nat. Biotechnol. 16 1998 153 157
150. A. Lucke, J. Kiermaier, and A. Göpferich Peptide acylation by poly(alpha-hydroxy esters) Pharm. Res. 19 2002 175 181
151. T. Horbett, and J.L. Brash Proteins at interfaces: current issues and future prospects J.L. Brash T. Horbett Proteins at Interfaces: Physicochemical and Biochemical Studies 1986 American Chemical Society Washington, DC 1 33
152. D.K.L. Xing, D.T. Crane, B. Bolgiano, M.J. Corbel, C. Jones, and D. Sesardic Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro Vaccine 14 1996 1205 1213
153. P.G. Shao, and L.C. Bailey Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics Pharm. Dev. Technol. 5 2000 1 9
154. M. Igartua, R.M. Hernandez, A. Esquisable, A.R. Gascon, M.B. Calvo, and J.L. Pedraz Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electriophoresis Int. J. Pharm. 169 1998 45 54